Introduction

Polymerase Chain Reaction (PCR) is one of the most important tools in modern molecular biology. It allows scientists to amplify specific DNA sequences, generating millions of copies from a tiny sample. At Hyseq, PCR is an essential part of our workflow, supporting research into rare and novel human genes and helping us advance the discovery of innovative treatments for human disease.

What is PCR?

PCR is a laboratory technique that uses enzymes to replicate DNA in a controlled environment. The process follows three main steps repeated in cycles:

1. Denaturation :separating the DNA strands at high temperature.
2. Annealing :binding of short DNA primers to the target sequence.
3. Extension :DNA polymerase synthesizes new DNA strands.

Within a few hours, PCR can produce enough DNA for sequencing, cloning, or diagnostic analysis.

Why PCR Matters to Hyseq

At Hyseq, we study rare and novel genes that often exist in very small quantities in biological samples. PCR allows us to:

• Amplify unique DNA regions for detailed sequencing and characterization.
• Detect genetic variations linked to rare disorders or complex diseases.
• Prepare samples for next-generation sequencing (NGS) and bioinformatics analysis.
• Support personalized medicine by identifying patient-specific genetic markers.

By integrating PCR into our genomics research pipeline, we ensure that even the most difficult-to-find genes can be studied with precision.

Applications in Human Genomics

PCR is not only a research tool, but also a cornerstone of modern biotechnology. Its applications relevant to Hyseq’s mission include:

• Disease gene discovery : identifying mutations associated with cancer, metabolic disorders, and immune system diseases.
• Drug development : screening genetic targets to support therapeutic innovation.
• Clinical diagnostics : enabling rapid detection of pathogens or hereditary risk factors.
• Gene expression studies : analyzing how novel genes influence biological pathways.

PCR and the Future of Hyseq

As genomic technologies continue to evolve, PCR remains a vital foundation for new innovations. At Hyseq, we combine PCR with next-generation sequencing (NGS), bioinformatics, and our expertise in rare gene discovery to push the boundaries of molecular medicine.

Our commitment is to transform these technologies into practical solutions that improve diagnostics, accelerate therapy development, and ultimately enhance human health.

Conclusion

PCR has revolutionized molecular biology, and at Hyseq it plays a central role in unlocking the secrets of rare genes. By combining this essential tool with advanced genomic research, Hyseq continues its mission to develop and commercialize new treatments for human disease.